RELEVENT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
State University of New York - Upstate Medical University
Fujian Cancer Hospital
Sichuan University
Fox Chase Cancer Center
Samsung Medical Center
Shandong New Time Pharmaceutical Co., LTD
Qianfoshan Hospital
Peking Union Medical College
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
The Netherlands Cancer Institute
Sichuan Cancer Hospital and Research Institute
European Lung Cancer Working Party
Emory University
Shanghai Yizhong Pharmaceutical Co., Ltd.
Guangdong Association of Clinical Trials
Zhejiang Teruisi Pharmaceutical Inc.
Jiangsu HengRui Medicine Co., Ltd.
Sun Yat-sen University
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Universitair Ziekenhuis Brussel
Sinocelltech Ltd.
Southwest Hospital, China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
Grupo de Investigación y Divulgación Oncológica
Samsung Medical Center
The Cooper Health System
Xinqiao Hospital of Chongqing
Cipla BioTec Pvt. Ltd.
First People's Hospital of Hangzhou
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Karolinska University Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sun Yat-sen University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Charite University, Berlin, Germany